Table 3. Blood parameters and vascularisation; prostate size < 70 mL.
Group A < 70 mL (placebo) | Group B < 70 mL (dutasteride) | p value | |
Hemoglobin before HoLEP, (g/dl) ± SD | 14.00 ± 2.02 | 14.24 ± 2.15 | 0.88 |
Hemoglobin after HoLEP, (g/dl) ± SD | 12.88 ± 1.94 | 12.99 ± 2.01 | 0.76 |
ΔHb ±SD | 1.12 ± 0.12 | 1.15 ± 0.13 | |
Hematocrit before HoLEP, % ± SD | 43.25 ± 3.90 | 42.18 ± 4.07 | 0.44 |
Hematocrit after HoLEP, % ± SD | 41.98 ± 4.03 | 41.17 ± 4.17 | 0.21 |
ΔHt ±SD | 1.17 ± 0.21 | 1.33 ± 0.20 | |
MVD | 23.35 ± 1.96 | 19.04 ± 0.96 | < .05 |
VEGF index | 4.06 ± 0.76 | 2.55 ± 0.55 | < .05 |
HoLEP: Holmium Laser Enucleation of the Prostate; MVD: microvascular density; VEGF index: vascular endothelial growth factor index; SD: standard deviation.